Advertisement

Ads Placeholder
Loading...

Biocartis Group NV

BIOGF•PNK
Healthcare
Medical - Diagnostics & Research
$0.66
$-3.84(-85.33%)
U.S. Market opens in 58h 2m

Biocartis Group NV (BIOGF) Stock Overview

Explore Biocartis Group NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap65.4M
P/E Ratio-0.53
EPS (TTM)$-0.98
ROE2.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

BIOGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biocartis Group NV (BIOGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.53 and a market capitalization of 65.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-85.33%
5-Year Change
-85.33%
All-Time (Max) Change
-85.33%

Contact Information

https://www.biocartis.com
32 1 563 20 00
Generaal de Wittelaan 11 B, Mechelen, NaN, 2800

Company Facts

5,260 Employees
IPO DateOct 14, 2021
CountryBE

Frequently Asked Questions